Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 3/2014

01-03-2014 | Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)

Innovative Uses of Electronic Health Records and Social Media for Public Health Surveillance

Authors: Emma M. Eggleston, Elissa R. Weitzman

Published in: Current Diabetes Reports | Issue 3/2014

Login to get access

Abstract

Electronic health records (EHRs) and social media have the potential to enrich public health surveillance of diabetes. Clinical and patient-facing data sources for diabetes surveillance are needed given its profound public health impact, opportunity for primary and secondary prevention, persistent disparities, and requirement for self-management. Initiatives to employ data from EHRs and social media for diabetes surveillance are in their infancy. With their transformative potential come practical limitations and ethical considerations. We explore applications of EHR and social media for diabetes surveillance, limitations to approaches, and steps for moving forward in this partnership between patients, health systems, and public health.
Literature
1.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. doi:10.​1056/​NEJM199309303291​401.
2.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53.
3.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. doi:10.​1056/​NEJMoa012512.PubMedCrossRef
4.
Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metabol. 2008;93:4774–9. doi:10.​1210/​jc.​2008-0772.CrossRef
5.
Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJG. Isolated hyperglycemia at 1 hour on oral glucose tolerance test in pregnancy resembles gestational diabetes mellitus in predicting postpartum metabolic dysfunction. Diabetes Care. 2008;31:1275–81. doi:10.​2337/​dc08-0126.PubMedCentralPubMedCrossRef
6.
7.
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Opthalmol. 1984;102:527–32.CrossRef
8.
Institute of Medicine. Living well with chronic illness: a call for public health action. Consensus Report; National Academies Press; 2012.
9.
10.
Anastasio S, Tabbot P. Independent study rough draft: 1 December 2012. The Public Health Significance of Implementing Electronic Health Records in New Jersey. The Public. 2012.
11.
Bailey LC, Milov DE, Kelleher K, Kahn MG, Del Beccaro M, Yu F, et al. Multi-institutional sharing of electronic health record data to assess childhood obesity. PloS One. 2013;8:e66192.PubMedCentralPubMedCrossRef
12.
Klompas M, Murphy M, Lankiewicz J, McVetta J, Lazarus R, Eggleston E, et al. Harnessing electronic health records for public health surveillance. J Public Health, Inform (online). 2011;3.
13.
14.
Bradley CA, Rolka H, Walker D, Loonsk J. BioSense: implementation of a National Early Event Detection and Situational Awareness System. MMWR MMWR. 2005;54(Suppl):11–9.
15.
Baker DW, Persell SD, Thompson JA, Soman NS, Burgner KM, Liss D, et al. Automated review of electronic health records to assess quality of care for outpatients with heart failure. Ann Intern Med. 2007;146:270–7.PubMedCrossRef
16.••
Klompas M, McVetta J, Lazarus R, Eggleston E, Haney G, Kruskal BA, et al. Integrating clinical practice and public health surveillance using electronic medical record systems. Am J Prev Med. 2012;42:S154–62. Review of EHR use for public health surveillance and detailed description of the Electronic Medical Recor Support for Public Health (ESP) project.PubMedCrossRef
17.
Ahmad FS, Tsang T. Diabetes prevention, health information technology, and meaningful use: challenges and opportunities. Am J Prev Med. 2013;44:S357–63.PubMedCrossRef
18.••
Friedman DJ, Parrish RG, Ross DA. Electronic health records and US public health: current realities and future promise. Am J Pub Health. 2013:e1–8. Comprehensive reivew of the potential of, and barriers to, the use of EHR data for public health surveillance and proposed steps to ensure that the use of EHR data to support public health reaches its full potential.
19.
Adler-Milstein J, Jha AK. Sharing clinical data electronically a critical challenge for fixing the health care system. JAMA. 2012;307:1695–6.PubMedCrossRef
20.
21.
Health IT Policy Committee. Meaningful use workgroup request for comments regarding meaningful use stage 2. In: Office of the National Coordinator for Health Information Technology, editor. Washington, DC; 2011.
22.
23.
Klompas M, McVetta J, Eggleston E, et al. Automated surveillance and public health reporting for gestational diabetes incidence and care using electronic health record data (Abstract). J Emerg Health Threats. 2011;4:S34.
24.•
Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care. 2013;36:914–21. Validation of public health diabetes surveillance algorithm to ascertain and distinguish type 1 from type 2 diabetes in the EHR.PubMedCrossRef
25.
Kudyakov R, Bowen J, Ewen E, West SL, Daoud Y, Fleming N, et al. Electronic health record use to classify patients with newly diagnosed vs preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Popul Health Manage. 2012;15:3–11.CrossRef
26.
27.
Makam AN, Nguyen OK, Moore B, Ma Y, Amarasingham R. Identifying patients with diabetes and the earliest date of diagnosis in real time: an electronic health record case-finding algorithm. BMC Med Inform Decis Mak. 2013;13:1–7.CrossRef
28.
Benin AL, Fenick A, Herrin J, Vitkauskas G, Chen J, Brandt C. How good are the data? Feasible approach to validation of metrics of quality derived from an outpatient electronic health record. Am J Med Qual. 2011;26:441–51. doi:10.​1177/​1062860611403136​.PubMedCrossRef
29.
Botsis T, Hartvigsen G, Chen F, Weng C. Secondary use of EHR: data quality issues and informatics opportunities. AMIA Summits Transl Sci Proc AMIA Summit Transl Sci. 2010;2010:1–5.
30.
31.
Chiolero A, Santschi V, Paccaud F. Public health surveillance with electronic medical records: at risk of surveillance bias and overdiagnosis. Eur J Pub Health. 2013;23:350–1. doi:10.​1093/​eurpub/​ckt044.CrossRef
32.
Hoffman S, Podgurski A. Big bad data: law, public health, and biomedical databases. J Law Med Ethics. 2013;41(Suppl):56–60.PubMed
33.
Fischer LR, Rush WA, Kluznik JC, O’Connor PJ, Hanson AM. Abstract C-C1-06: identifying depression among diabetes patients using natural language processing of office notes. Clin Med Res. 2008;6:125–6.CrossRef
34.
35.
36.
37.
Brown JS, Holmes JH, Shah K, Hall K, Lazarus R, Platt R. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care. 2010;48(6 Suppl):S45–51. doi:10.​1097/​MLR.​0b013e3181d9919f​.PubMedCrossRef
38.
Maro JC, Platt R, Holmes JH, Strom BL, Hennessy S, Lazarus R, et al. Design of a national distributed health data network. Ann Intern Med. 2009;151:341–4.PubMedCrossRef
39.
40.
Lenert L, Sundwall DN. Public health surveillance and meaningful use regulations: a crisis of opportunity. J Inform. 2012;102:e1–7.
41.
42.
Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care. 2010;33:2190–5.PubMedCentralPubMedCrossRef
43.
44.
Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care. 2011;34:84–9.PubMedCentralPubMedCrossRef
45.
Balion CM, Raina PS, Gerstein HC, Santaguida PL, Morrison KM, Booker L, et al. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Clin Chem Lab Med. 2007;45:1180–5. doi:10.​1515/​CCLM.​2007.​505.PubMedCrossRef
46.
Saukkonen T, Cederberg H, Jokelainen J, Laakso M, Härkönen P, Keinänen-Kiukaanniemi S, et al. Limited overlap between intermediate hyperglycemia as defined by A1C 5.7–6.4 %, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care. 2011;34:2314–6.PubMedCentralPubMedCrossRef
47.
Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care. 2010;33:580–2. doi:10.​2337/​dc09-1843.PubMedCentralPubMedCrossRef
48.
49.
Herranz L, Saez-de-Ibarra L, Grande C, Pallardo LF. Non–glycemic-dependent reduction of late pregnancy A1C levels in women with type 1 diabetes. Diabetes Care. 2007;30:1579–80. doi:10.​2337/​dc06-2568.PubMedCrossRef
50.••
Centers for Disease Control and Prevention. HIPAA Privacy Rule and Public Health: Guidance from CDC and the US Department of Health and Human Services. MMWR 2003;1–20. Report on the application and interpretation of HIPAA privacy rules for the use of clinical data in public health surveillance.
51.
Madden M, Zickuhr K. 65 % of online adults use social networking sites. Washington: Pew Research Center; 2011.
52.
Chou WY, Hunt YM, Beckjord EB, Moser RP, Hesse BW. Social media use in the United States: implications for health communication. J Med Internet Res. 2009;11:e48.PubMedCentralPubMedCrossRef
53.
Fox S, Purcell K. Chronic disease and the internet. Washington: Pew Research Center; 2010.
54.
55.••
Weitzman ER, Cole E, Kaci L, Mandl KD. Social but safe? Quality and safety of diabetes-related online social networks. JAMIA. 2011;18:292–7. doi:10.​1136/​jamia.​2010.​009712. Multi-site evaluation of the quality and safety of the 10 most frequently referenced online diabetes social networking sites. A structured measurement protocol was used to rate sites along 28 indicators of quality and safety across 4 domains.PubMedCentralPubMed
56.
Frost JH, Massagli MP. Social uses of personal health information within PatientsLikeMe, an online patient community: what can happen when patients have access to one another's data. J Med Internet Res. 2008;10:e15.PubMedCentralPubMedCrossRef
57.
Seeman N. Web 2.0 and chronic illness: new horizons, new opportunities. Healthcare Q. 2008;11:104–8. 10, 4.CrossRef
58.
59.
60.
61.
Greene JA, Choudhry NK, Kilabuk E, Shrank WH. Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med. 2010;26(3):287–92.PubMedCentralPubMedCrossRef
62.
63.
64.
65.
Hughes SL, Weaver FM, Giobbie-Hurder A, Manheim L, Henderson W, Kubal JD, et al. Effectiveness of team-managed home-based primary care: a randomized multi-center trial. JAMA. 2000;284:2877–85.PubMedCrossRef
66.
Bousquet J, Bousquet PJ, Godard P, Daures JP. The public health implications of asthma. Bull World Health Organ. 2005;83:548–54.PubMedCentralPubMed
67.
68.
69.
Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health Aff. 2009;28:64–74.CrossRef
70.
71.
Kohane IS, Altman RB. Health-information altruists—a potentially critical resource. N Engl J Med. 2005;353:2074–7.PubMedCrossRef
72.
73.
74.
Signorini A, Segre AM, Polgreen PM. The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. PloS One. 2011;6:e19467.PubMedCentralPubMedCrossRef
75.
76.
77.••
Chunara R, Bouton L, Ayers JW, Brownstein JS. Assessing the online social environment for surveillance of obesity prevalence. PLoS One. 2013;8:e61373. doi:10.​1371/​journal.​pone.​0061373. This cross-sectional observational study among Facebook users examined the relationship between Facebook use and specific interests posted and prevalence of obesity and overweight in US as measured by the Behavioral Risk Factor Surveillance System (BRFSS) and across New York City neighborhoods as measured by NYC EpiQuery.PubMedCentralPubMedCrossRef
78.
79.
van Noort SP, Muehlen M, Rebelo de Andrade H, Koppeschaar C, Lima Lourenco JM, Gomes MG. Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe. Eur Surveill. 2007;12:E5–6.
80.
Brownstein JS, Freifeld CC, Madoff LC. Digital disease detection—harnessing the Web for public health surveillance. N Engl J Med. 2009;360:2153–5. 7.PubMedCentralPubMedCrossRef
81.
Weitzman ER, Kelemen S, Mandl KD. Surveillance of an online social network to assess population-level diabetes health status and healthcare quality. J Pub Health, Inform (Online). 2011;3.
82.
83.
84.
85.
Frost J, Okun S, Vaughan T, Heywood J, Wicks P. Patient-reported outcomes as a source of evidence in off-label prescribing: analysis of data from PatientsLikeMe. J Med Internet Res. 2011;13:e6.PubMedCentralPubMedCrossRef
86.
87.
88.
Adida B, Sanyal A, Zabak S, Kohane IS, Mandl KD. Indivo x: developing a fully substitutable personally controlled health record platform. AMIA Ann Symp Proc / AMIA Symp. 2010;2010:6–10.
89.••
Weitzman ER, Kelemen S, Quinn M, Eggleston EM, Mandl KD. Participatory surveillance of hypoglycemia and harms in an online social network. JAMA Intern Med. 2013;173:345–51. doi:10.​1001/​jamainternmed.​2013.​2512. This cross-sectional survey used a freely available software app to engage members of an online international diabetes social network in reporting about hypoglycemia frequency, severity, and impact.PubMedCrossRef
90.
91.•
Redberg RF. Online network for adverse event reporting. JAMA Intern Med. 2013;173:352–3. doi:10.​1001/​jamainternmed.​2013.​3445. Editorial on the importance of social media surveillance of hypoglycemia and harms as a novel means for post-marketing drug safety surveillance.
92.
Rhodes SD, Bowie DA, Hergenrather KC. Collecting behavioral data using the world wide web: considerations for researchers. J Epidemiol Community Health. 2003;57:68–73.PubMedCentralPubMedCrossRef
93.
94.••
Vayena E, Tasioulas J. Adapting standards: ethical oversight of participant-led health research. PLoS Med. 2013;10:e1001402. doi:10.​1371/​journal.​pmed.​1001402. This policy forum report describes the ethical context for participant-led research and proposes a framework for consenting cohorts and providing ethical oversight.PubMedCentralPubMedCrossRef
95.
Quinn E, Corrigan M, McHugh S, Murphy D, O'Mullane J, Hill A, et al. Who's talking about breast cancer? Analysis of daily breast cancer posts on the internet. Breast. 2013;22:24–7.PubMedCrossRef
Metadata
Title
Innovative Uses of Electronic Health Records and Social Media for Public Health Surveillance
Authors
Emma M. Eggleston
Elissa R. Weitzman
Publication date
01-03-2014
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 3/2014
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-013-0468-7

Other articles of this Issue 3/2014

Current Diabetes Reports 3/2014 Go to the issue

Hospital Management of Diabetes (G Umpierrez, Section Editor)

Diabetes in Long-Term Care Facilities

Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)

Quality Indicators and Performance Measures in Diabetes Care

Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)

Integrated Community-Healthcare Diabetes Interventions to Reduce Disparities

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

How Do We Know if the Brain Is Wired for Type 2 Diabetes?

Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)

A Review of Advances in Collaborative Pharmacy Practice to Improve Adherence to Standards of Care in Diabetes Management

Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)

Effectiveness of Diabetes Interventions in the Patient-Centered Medical Home
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits